TISSIUM
Jeff Karp is a Co-Founder & Board Observer at TISSIUM. Jeff has also worked as Broad Institute, Landsdowne Labs, TEDMED, Frequency Therapeutics, TISSIUM, Alivio Therapeutics, Partners HealthCare, and Skintifique. Jeff has also worked as Brigham and Women's Hospital.
Jeff Karp completed a PhD in Chemical and Biomedical Engineering at the University of Toronto. Jeff then went on to complete a postdoc in Stem Cells and Advanced Biomaterials at the Massachusetts Institute of Technology. Jeff Karp also holds a BENG in Chemical Engineering from McGill University and has a certification from Scoutible in Strengths Resume.
This person is not in the org chart
This person is not in any offices
TISSIUM
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.